Literature DB >> 64934

Immunosuppression by mouse sialylated alpha-foetoprotein.

E F Zimmerman, M Voorting-Hawking, J G Michael.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 64934     DOI: 10.1038/265354a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Effects of human alpha-foetoprotein on human B and T lymphocyte proliferation in vitro.

Authors:  R A Murgita; L C Andersson; M S Sherman; H Bennich; H Wigzell
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

2.  Thymic involution in pregnant mice. II. Functional aspects of the remaining thymocytes.

Authors:  L H Phuc; M Papiernik; M Dardenne
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

3.  Proteins in cerebrospinal fluid and plasma of fetal sheep during development.

Authors:  K M Dziegielewska; C A Evans; G Fossan; F L Lorscheider; D H Malinowska; K Møllgård; M L Reynolds; N R Saunders; S Wilkinson
Journal:  J Physiol       Date:  1980-03       Impact factor: 5.182

4.  [T-lymphocyte activation. Studies on the function of mediator proteins (author's transl)].

Authors:  E Köttgen; H A Fabricius; R Stahn; W Gerok
Journal:  Klin Wochenschr       Date:  1981-06-15

5.  Isolation and characterization of a distinct immunoregulatory isoform of alpha-fetoprotein produced by the normal fetus.

Authors:  N S van Oers; B L Cohen; R A Murgita
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

6.  Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. I. Selective inhibition of anti-Ia-associated proliferative reactions.

Authors:  A B Peck; R A Murgita; H Wigzell
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

7.  Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. II. Alpha-fetoprotein-induced suppression of cytotoxic T lymphocyte development.

Authors:  A B Peck; R A Murgita; H Wigzell
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.